Bioelectronics Corp (BIEL)

[The_Pro]

TO BE NOTED:

Deferred revenue was still not fully consummated.

Deferred revenue Q2 2021. $555,585.00

Burnt revenue Q3 2021 $299,187.00
___________________________________________

Residual Revenue for Q4+ 2021 $256,398.00

More profitable quarters ahead especially with cost of goods sold coming way down to 31% of gross sales, ie ties to net profit. See Srinsocal's post #278834

What I really got from that PR release was this:

"The Research and Development team is expanding its efforts regarding the brain stimulation project by collaborating with the Clinical Science and Engineering Research Lab at Binghamton University under the guidance of Ken McLeod, Ph.D. The vision behind this research undertaking is to develop and optimize PSWT technology that will be capable of serving as a therapeutic intervention for psychological disorders such as depression and anxiety."

BIEL IS EXPANDING ITS LINEAGE OF USAGE.

This statement is so in line with ActiPatch usage for Migraine headaches. I bet we see a 510k medical device FDA clearance in this direction. IMAGINE CLINICALLY TRIAL PROVEN FOR MIGRAINE HEADACHES.

I am so relieved we are moving forward in leaps and bounds.

It's all patience here folks.